About Montara Therapeutics
Montara Therapeutics is a private company based in San Francisco, California, incorporated in 2022 in Delaware. It has reported $28,000,006 raised in two offerings on Form D since January 2024. Its chief executive is Nicholas Hertz.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Feb 26, 2025 | Mar 13, 2025 | $19,999,995fully sold | 9 | $2.2M | EquityRule 506(b) | Form D ↗ |
| Jan 5, 2024 | Jan 19, 2024 | $8,000,011of $17.0M target | 5 | $1.6M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $28,000,006 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Montara Therapeutics's Form D filed Mar 13, 2025.
ML
Max Lebovitz
Executive officer
SS
Seth Stratton
Director
TW
ZH
Zachary Hill
Executive officer
RR
Rishi Rakhit
Executive officer
RC
Randall Chin
Executive officer
DL
Dirk Langdorf
Director
NH
Nicholas Hertz
President & CEO, director